P&G Portfolio Reduction Stirs Pot Of Consumer Health Acquisition Targets
This article was originally published in The Tan Sheet
Executive Summary
Prestige Brands sees “a sea change” in consumer health care products available for acquisition with P&G’s plan to halve its portfolio. Analysts are positive on the move, but question whether shedding roughly $1 billion in brands from an $80 billion portfolio is sufficient for P&G’s needs.